KEGG   DRUG: OcriplasminHelp
Entry
D09646                      Drug                                   

Name
Ocriplasmin (USAN/INN);
Ocriplasmin (genetical recombination) (JAN);
Jetrea (TN)
Product
Formula
C1214H1890N338O348S14
Exact mass
27219.6676
Mol weight
27236.9622
Remark
ATC code: S01XA22
Product: D09646<US>
Efficacy
Cell adhesion molecule
Comment
recombinant C-terminal fragment of human plasmin [EC:3.4.21.7]
Cardiovascular agent
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01X OTHER OPHTHALMOLOGICALS
    S01XA Other ophthalmologicals
     S01XA22 Ocriplasmin
      D09646  Ocriplasmin (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D09646
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D09646
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D09646
BRITE hierarchy
Other DBs
CAS: 1048016-09-6
PubChem: 124490386
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system